Newly Launched Tome Biosciences Acquires Replace Therapeutics for $65M

Tome Biosciences, which recently came into the biotech world with over $200 million in its arsenal, has secured an acquisition of Replace Therapeutics for $65 million upfront and “near-term” milestones, according to Tuesday’s announcement.